77 related articles for article (PubMed ID: 38514636)
41. CHAC2 is essential for self-renewal and glutathione maintenance in human embryonic stem cells.
Wang CK; Yang SC; Hsu SC; Chang FP; Lin YT; Chen SF; Cheng CL; Hsiao M; Lu FL; Lu J
Free Radic Biol Med; 2017 Dec; 113():439-451. PubMed ID: 29054545
[TBL] [Abstract][Full Text] [Related]
42. Targeting Epigenetics in Cancer.
Bennett RL; Licht JD
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
[TBL] [Abstract][Full Text] [Related]
43. CHAC2, downregulated in gastric and colorectal cancers, acted as a tumor suppressor inducing apoptosis and autophagy through unfolded protein response.
Liu S; Fei W; Shi Q; Li Q; Kuang Y; Wang C; He C; Hu X
Cell Death Dis; 2017 Aug; 8(8):e3009. PubMed ID: 28837156
[TBL] [Abstract][Full Text] [Related]
44. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
[TBL] [Abstract][Full Text] [Related]
45. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.
Ricken R; Ulrich S; Schlattmann P; Adli M
Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071
[TBL] [Abstract][Full Text] [Related]
46. LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis.
Lee JY; Park JH; Choi HJ; Won HY; Joo HS; Shin DH; Park MK; Han B; Kim KP; Lee TJ; Croce CM; Kong G
Oncogene; 2017 Sep; 36(39):5512-5521. PubMed ID: 28534506
[TBL] [Abstract][Full Text] [Related]
47. LSD1: biologic roles and therapeutic targeting.
Maiques-Diaz A; Somervaille TC
Epigenomics; 2016 Aug; 8(8):1103-16. PubMed ID: 27479862
[TBL] [Abstract][Full Text] [Related]
48. The Latent Membrane Protein 1 (LMP1).
Kieser A; Sterz KR
Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
[TBL] [Abstract][Full Text] [Related]
49. LSD1 overexpression is associated with poor prognosis in basal-like breast cancer, and sensitivity to PARP inhibition.
Nagasawa S; Sedukhina AS; Nakagawa Y; Maeda I; Kubota M; Ohnuma S; Tsugawa K; Ohta T; Roche-Molina M; Bernal JA; Narváez AJ; Jeyasekharan AD; Sato K
PLoS One; 2015; 10(2):e0118002. PubMed ID: 25679396
[TBL] [Abstract][Full Text] [Related]
50. Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma.
Theisen ER; Gajiwala S; Bearss J; Sorna V; Sharma S; Janat-Amsbury M
BMC Cancer; 2014 Oct; 14():752. PubMed ID: 25300887
[TBL] [Abstract][Full Text] [Related]
51. The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma.
Anderton JA; Bose S; Vockerodt M; Vrzalikova K; Wei W; Kuo M; Helin K; Christensen J; Rowe M; Murray PG; Woodman CB
Oncogene; 2011 Apr; 30(17):2037-43. PubMed ID: 21242977
[TBL] [Abstract][Full Text] [Related]
52. Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells.
Cho HS; Suzuki T; Dohmae N; Hayami S; Unoki M; Yoshimatsu M; Toyokawa G; Takawa M; Chen T; Kurash JK; Field HI; Ponder BA; Nakamura Y; Hamamoto R
Cancer Res; 2011 Feb; 71(3):655-60. PubMed ID: 21115810
[TBL] [Abstract][Full Text] [Related]
53. Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes.
Yang J; Huang J; Dasgupta M; Sears N; Miyagi M; Wang B; Chance MR; Chen X; Du Y; Wang Y; An L; Wang Q; Lu T; Zhang X; Wang Z; Stark GR
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21499-504. PubMed ID: 21098664
[TBL] [Abstract][Full Text] [Related]
54. Lysine methylation regulates E2F1-induced cell death.
Kontaki H; Talianidis I
Mol Cell; 2010 Jul; 39(1):152-60. PubMed ID: 20603083
[TBL] [Abstract][Full Text] [Related]
55. Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2.
Binda C; Valente S; Romanenghi M; Pilotto S; Cirilli R; Karytinos A; Ciossani G; Botrugno OA; Forneris F; Tardugno M; Edmondson DE; Minucci S; Mattevi A; Mai A
J Am Chem Soc; 2010 May; 132(19):6827-33. PubMed ID: 20415477
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers.
Hayami S; Kelly JD; Cho HS; Yoshimatsu M; Unoki M; Tsunoda T; Field HI; Neal DE; Yamaue H; Ponder BA; Nakamura Y; Hamamoto R
Int J Cancer; 2011 Feb; 128(3):574-86. PubMed ID: 20333681
[TBL] [Abstract][Full Text] [Related]
57. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.
Schulte JH; Lim S; Schramm A; Friedrichs N; Koster J; Versteeg R; Ora I; Pajtler K; Klein-Hitpass L; Kuhfittig-Kulle S; Metzger E; Schüle R; Eggert A; Buettner R; Kirfel J
Cancer Res; 2009 Mar; 69(5):2065-71. PubMed ID: 19223552
[TBL] [Abstract][Full Text] [Related]
58. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation.
Wang J; Hevi S; Kurash JK; Lei H; Gay F; Bajko J; Su H; Sun W; Chang H; Xu G; Gaudet F; Li E; Chen T
Nat Genet; 2009 Jan; 41(1):125-9. PubMed ID: 19098913
[TBL] [Abstract][Full Text] [Related]
59. Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A.
Mimasu S; Sengoku T; Fukuzawa S; Umehara T; Yokoyama S
Biochem Biophys Res Commun; 2008 Feb; 366(1):15-22. PubMed ID: 18039463
[TBL] [Abstract][Full Text] [Related]
60. Lysine demethylase LSD1 is associated with stemness in EBV-positive B cell lymphoma.
Kim JH; Park C; Kim WS
Sci Rep; 2024 Mar; 14(1):6764. PubMed ID: 38514636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
